SYBX
Synlogic Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ynlogictx.com
- Employees(FY) 72
- ISIN US87166L2097
Performance
-9.84%
1W
-8.33%
1M
-8.59%
3M
-17.09%
6M
-57.14%
YTD
-80.5%
1Y
Profile
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase II clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.
Technical Analysis of SYBX 2024-05-10
Overview:
In analyzing the technical indicators for SYBX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and recommendations for potential future price action.
...Recent News & Updates
- 2024-05-14 01:54
- 2024-05-13 19:00
Synlogic Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-03-18 20:10
- 2024-03-18 19:00
- 2024-02-19 23:15
Synlogic Adopts Limited Duration Stockholders Rights Plan(Globenewswire)
- 2024-02-08 20:41
- 2024-02-08 19:42
Why Is Synlogic (SYBX) Stock Down 55% Today?(Investorplace)
- 2024-02-08 16:47
- 2024-02-08 03:15
- 2024-02-01 23:00
- 2024-01-15 19:47
Sidoti Events, LLC's Virtual January Micro-Cap Conference(Yahoo Finance)
- 2024-01-03 18:00
Synlogic Provides Corporate Update and Outlook for 2024(Globenewswire)
- 2023-12-26 18:00
Synlogic Announces Contract with the Air Force Research Lab(Globenewswire)
- 2023-12-06 18:00
- 2023-11-13 19:55
Sidoti Events, LLCs Virtual November Micro-Cap Conference(Yahoo Finance)
- 2023-11-08 18:19
- 2023-11-08 18:00
- 2023-11-06 18:00
- 2023-11-01 22:00
- 2023-10-03 04:15
- 2023-09-28 19:00
- 2023-09-27 23:15
- 2023-09-27 21:13
Why Is Synlogic (SYBX) Stock Down 6% Today?(Investorplace)
- 2023-09-27 00:30
Synlogic Announces Reverse Stock Split(Globenewswire)
- 2023-09-20 19:00
- 2023-09-18 23:00
- 2023-08-09 20:40
- 2023-08-09 19:00
- 2023-07-10 19:00
- 2023-06-27 19:00
Page 1 of 4
previousnext